tiprankstipranks
Trending News
More News >
InnoCare Pharma Ltd. (HK:9969)
:9969
Hong Kong Market

InnoCare Pharma Ltd. (9969) Income Statement

Compare
1 Followers

InnoCare Pharma Ltd. Income Statement

Last quarter (Q4 2024), InnoCare Pharma Ltd.'s total revenue was ¥311.70M, an increase of 54.94% from the same quarter last year. In Q4, InnoCare Pharma Ltd.'s net income was ¥-165.22M. See InnoCare Pharma Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 1.01B¥ 738.54M¥ 625.40M¥ 1.04B¥ 1.36M
Gross Profit
¥ 871.01M¥ 610.10M¥ 482.01M¥ 977.37M¥ 1.36M
Operating Expenses
¥ 1.40B¥ 1.26B¥ 1.21B¥ 1.14B¥ 495.91M
Depreciation and Amortization
¥ 57.99M¥ 92.62M¥ 68.40M¥ 33.71M¥ 11.45M
EBITDA
¥ -463.49M¥ -516.55M¥ -808.28M¥ 16.23M¥ -453.44M
Operating Income
¥ -531.61M¥ -651.15M¥ -891.63M¥ -24.25M¥ -464.89M
Other Income/Expenses
¥ 79.01M¥ 6.95M¥ -525.11K¥ 146.12M¥ 73.03M
Pretax Income
¥ -452.59M¥ -644.21M¥ -893.73M¥ -20.12M¥ -464.26M
Net Income
¥ -440.63M¥ -631.26M¥ -871.65M¥ -66.68M¥ -463.17M
Per Share Metrics
Basic EPS
¥ -0.26¥ -0.37¥ -0.59¥ -0.05¥ -0.48
Diluted EPS
¥ -0.26¥ -0.37¥ -0.59¥ -0.05¥ -0.48
Weighted Average Shares Outstanding
1.69B 1.71B 1.48B 1.37B 967.58M
Weighted Average Shares Outstanding (Diluted)
1.69B 1.71B 1.48B 1.37B 967.58M
Currency in CNY

InnoCare Pharma Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis